Hartvig Camilla Harder

Insider profile

Hartvig Camilla Harder's trades of Ascendis Pharma A/S's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-03-04 2025-03-04 PrS Proposed sale
91,198
198.42
US$4,251,765
91,198 198.42 US$4,251,765
2024-11-19 2024-11-19 PrS Proposed sale
44,908
424.10
US$2,120,567
44,908 424.10 US$2,120,567